Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2035.00 | 1997.25 | 1.0189 | 1.0298 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3865.00 | 3836.75 | 1.0074 | 1.0141 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3784.00 | 3836.75 | 0.9863 | 0.9736 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3698.00 | 3836.75 | 0.9638 | 0.9306 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1861.36 | 3934.00 | 3836.75 | 1.0253 | 1.0486 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1861.36 | 3835.00 | 3836.75 | 0.9995 | 0.9991 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3227.00 | 3836.75 | 0.8411 | 0.6943 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 1868.00 | 3836.75 | 0.4869 | 0.0034 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 2333.00 | 3836.75 | 0.6081 | 0.2416 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1861.36 | 3907.00 | 3836.75 | 1.0183 | 1.0351 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4073.00 | 3836.75 | 1.0616 | 1.1179 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1861.36 | 1871.00 | 3836.75 | 0.4877 | 0.0050 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 4108.00 | 3836.75 | 1.0707 | 1.1353 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1798.00 | 3836.75 | 0.4686 | -0.0326 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 3882.00 | 3836.75 | 1.0118 | 1.0226 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3387.00 | 3836.75 | 0.8828 | 0.7748 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4099.00 | 3836.75 | 1.0684 | 1.1308 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 3651.00 | 3836.75 | 0.9516 | 0.9071 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 2500.00 | 1861.36 | 4088.00 | 3836.75 | 1.0655 | 1.1253 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1861.36 | 4013.00 | 3836.75 | 1.0459 | 1.0880 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 1842.00 | 3836.75 | 0.4801 | -0.0100 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1567.00 | 3836.75 | 0.4084 | -0.1521 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3665.00 | 3836.75 | 0.9552 | 0.9141 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3554.00 | 3836.75 | 0.9263 | 0.8585 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 2500.00 | 1861.36 | 3359.00 | 3836.75 | 0.8755 | 0.7607 |